52 results
Page 2 of 3
6-K
EX-99.2
v2ub6ygrrjper1x
14 Nov 22
Condensed Financial Statements
5:02pm
6-K
EX-99.3
m376r lbv7lrrx4
15 Aug 22
Current report (foreign)
6:16pm
6-K
EX-99.2
ly6dr9q8hn uzgu626dz
15 Aug 22
Current report (foreign)
6:16pm
6-K
EX-99.1
uslybzohe7d1fnn
29 Jul 22
Investor Presentation July 2022
4:30pm
6-K
EX-99.2
91d3k
16 May 22
Condensed Financial Statements
4:31pm
6-K
EX-99.2
dnqhfeqpkzco 8kh31l
15 Nov 21
Condensed Financial Statements
4:15pm
6-K
EX-99.2
lan4rc29m01ej
16 Aug 21
Current report (foreign)
8:17am
6-K
EX-99.3
6jzmomuu
13 May 21
PAINREFORM LTD. Condensed UNAUDITED FINANCIAL STATEMENTS
9:18am
6-K
EX-99.2
ylrq2qdy5lusj7dt
13 May 21
PAINREFORM LTD. Condensed UNAUDITED FINANCIAL STATEMENTS
9:18am
20-F
rdbl fk9rlcnz
18 Mar 21
Annual report (foreign)
9:03am
6-K
EX-99.1
9dcx04lzv
5 Jan 21
Investor Presentation January 2021
4:15pm
6-K
EX-99.1
6b9q4mgtg8qvr0
4 Jan 21
PainReform Announces Appointment of Lotus Clinical Research as CRO for Phase 3 Clinical Trial of PRF-110
4:16pm
6-K
EX-99.1
wbahp28lnnx4
19 Oct 20
PainReform Highlights Surgical Advantages of PRF-110
1:37pm
424B3
gfn4iowj6xovf0
30 Sep 20
Prospectus supplement
4:42pm
6-K
EX-99.2
hbv76 6jg11f
30 Sep 20
Condensed Financial Statements
4:32pm
424B4
j3ruglkizzpvf46ljo2t
2 Sep 20
Prospectus supplement with pricing info
4:09pm
F-1/A
1crx227zd50iza36x
31 Aug 20
Registration statement (foreign) (amended)
6:06am
F-1/A
EX-10.2
nwjj1w t0yt5
24 Aug 20
Registration statement (foreign) (amended)
12:15pm
F-1/A
s2oupqxuwp0 4wwnlkx
24 Aug 20
Registration statement (foreign) (amended)
12:15pm